rel	B-protein
Is	O
rapidly	O
tyrosine-phosphorylated	O
following	O
granulocyte-colony	B-protein
stimulating	I-protein
factor	I-protein
treatment	O
of	O
human	O
neutrophils	O
.	O

Stimulation	O
of	O
neutrophils	B-cell_type
with	O
granulocyte-colony	B-protein
stimulating	I-protein
factor	I-protein
(	O
G-CSF	B-protein
)	O
results	O
in	O
an	O
enhanced	O
respiratory	O
burst	O
,	O
prolonged	O
survival	O
,	O
and	O
increased	O
tumor	O
cell	O
killing	O
.	O

The	O
effects	O
of	O
G-CSF	B-protein
are	O
mediated	O
by	O
binding	O
to	O
specific	O
,	O
high	O
affinity	B-protein
receptors	I-protein
.	O

G-CSF	B-protein
receptors	I-protein
lack	O
intrinsic	O
tyrosine	B-protein
kinase	I-protein
activity	O
,	O
but	O
activation	O
of	O
the	O
receptor	O
results	O
in	O
the	O
rapid	O
induction	O
of	O
tyrosine	O
kinase	O
activity	O
.	O

Antiphosphotyrosine	O
immunoblots	O
of	O
whole	O
cell	O
lysates	O
prepared	O
from	O
neutrophils	B-cell_type
show	O
that	O
the	O
G-CSF	B-protein
rapidly	O
induces	O
prominent	O
tyrosine	O
phosphorylation	O
of	O
a	O
protein	O
of	O
a	O
relative	O
molecular	O
mass	O
of	O
80	O
kDa	O
.	O

Using	O
monospecific	B-protein
antibodies	I-protein
,	O
the	O
80-kDa	O
tyrosine-phosphorylated	B-protein
protein	I-protein
has	O
been	O
shown	O
to	O
be	O
p80c-rel	B-protein
,	O
a	O
proto-oncogene	B-DNA
belonging	O
to	O
a	O
family	O
of	O
transcriptional	B-protein
regulators	I-protein
which	O
include	O
NF-kB	B-protein
.	O

The	O
induction	O
of	O
tyrosine	O
phosphorylation	O
of	O
p80c-rel	B-protein
was	O
unique	O
to	O
G-CSF	B-protein
in	O
that	O
granulocyte-macrophage	B-protein
colony	I-protein
stimulating	I-protein
factor	I-protein
which	O
also	O
stimulates	O
neutrophils	B-cell_type
and	O
induces	O
tyrosine	O
phosphorylation	O
does	O
not	O
result	O
in	O
tyrosine	O
phosphorylation	O
of	O
p80c-rel	B-protein
.	O

The	O
consequences	O
of	O
p80c-rel	B-protein
tyrosine	O
phosphorylation	O
are	O
not	O
yet	O
known	O
;	O
however	O
,	O
tyrosine-phosphorylated	O
p80c-rel	B-protein
is	O
capable	O
of	O
binding	O
to	O
DNA	O
,	O
and	O
G-CSF	B-protein
stimulation	O
results	O
in	O
an	O
increase	O
in	O
the	O
amount	O
of	O
p80c-rel	B-protein
which	O
binds	O
to	O
DNA	O
.	O

These	O
results	O
demonstrate	O
that	O
one	O
of	O
the	O
first	O
biochemical	O
events	O
which	O
occurs	O
in	O
neutrophils	B-cell_type
following	O
G-CSF	B-protein
stimulation	O
,	O
activation	O
of	O
a	O
tyrosine	B-protein
kinase	I-protein
,	O
leads	O
directly	O
to	O
the	O
tyrosine	O
phosphorylation	O
of	O
p80c-rel	B-protein
.	O

Thus	O
,	O
the	O
tyrosine	B-protein
kinase	I-protein
activated	O
by	O
G-CSF	B-protein
appears	O
to	O
directly	O
transduce	O
a	O
signal	O
to	O
a	O
protein	O
which	O
functions	O
as	O
a	O
transcriptional	B-protein
regulator	I-protein
.	O

Tes	NULL
Journat	NULL
or	NULL
Brorocicat	NULL
Cremistry	NULL
©	NULL
1994	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biclogy	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

269	NULL
,	NULL
No	NULL
.	NULL

7	NULL
,	NULL
Issue	NULL
of	NULL
February	NULL
18	NULL
,	NULL
pp	NULL
.	NULL

5387-5390	NULL
,	NULL
1994	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
rel	NULL
Is	NULL
Rapidly	NULL
Tyrosine-phosphorylated	NULL
following	NULL
Granulocyte-Colony	NULL
Stimulating	NULL
Factor	NULL
Treatment	NULL
of	NULL
Human	NULL
Neutrophils*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
September	NULL
29	NULL
,	NULL
1993	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
November	NULL
9	NULL
,	NULL
1993	NULL
)	NULL
Brian	NULL
J.	NULL
Drukert§	NULL
,	NULL
Manfred	NULL
Neumann	NULL
!	NULL

{	NULL
,	NULL
Keiko	NULL
Okuda**	NULL
,	NULL
B.	NULL
Robert	NULL
Franza	NULL
,	NULL
Jr.1	NULL
,	NULL
and	NULL
James	NULL
D.	NULL
Griffin**	NULL
From	NULL
the	NULL
{	NULL
Division	NULL
of	NULL
Cellular	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
**Division	NULL
of	NULL
Tumor	NULL
Immunology	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
and	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
Massachusetts	NULL
02115	NULL
and	NULL
the	NULL
Freeman	NULL
Laboratory	NULL
of	NULL
Cancer	NULL
Cell	NULL
Biology	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
New	NULL
York	NULL
11724	NULL
Stimulation	NULL
of	NULL
neutrophils	NULL
with	NULL
granulocyte-colony	NULL
stimulating	NULL
factor	NULL
(	NULL
G-CSF	NULL
)	NULL
results	NULL
in	NULL
an	NULL
enhanced	NULL
respiratory	NULL
burst	NULL
,	NULL
prolonged	NULL
survival	NULL
,	NULL
and	NULL
increased	NULL
tumor	NULL
cell	NULL
killing	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
G-CSF	NULL
are	NULL
mediated	NULL
by	NULL
binding	NULL
to	NULL
specific	NULL
,	NULL
high	NULL
affinity	NULL
receptors	NULL
.	NULL

G-CSF	NULL
receptors	NULL
lack	NULL
intrinsic	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
,	NULL
but	NULL
activation	NULL
of	NULL
the	NULL
receptor	NULL
results	NULL
in	NULL
the	NULL
rapid	NULL
induction	NULL
of	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
.	NULL

Antiphosphotyrosine	NULL
immunoblots	NULL
of	NULL
whole	NULL
cell	NULL
lysates	NULL
prepared	NULL
from	NULL
neutrophils	NULL
show	NULL
that	NULL
the	NULL
G-CSF	NULL
rapidly	NULL
induces	NULL
prominent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
protein	NULL
of	NULL
a	NULL
relative	NULL
molecular	NULL
mass	NULL
of	NULL
80	NULL
kDa	NULL
.	NULL

Using	NULL
monospecific	NULL
antibodies	NULL
,	NULL
the	NULL
80-kDa	NULL
tyrosine-phosphorylated	NULL
protein	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
p80°	NULL
``	NULL
``	NULL
``	NULL
,	NULL
a	NULL
proto-oncogene	NULL
belonging	NULL
to	NULL
a	NULL
family	NULL
of	NULL
transcriptional	NULL
regulators	NULL
which	NULL
include	NULL
NF-kB	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p80°	NULL
``	NULL
``	NULL
``	NULL
was	NULL
unique	NULL
to	NULL
G-CSF	NULL
in	NULL
that	NULL
granulocyte-macrophage	NULL
colony	NULL
stimulating	NULL
factor	NULL
which	NULL
also	NULL
stimulates	NULL
neutrophils	NULL
and	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
does	NULL
not	NULL
result	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p80°	NULL
``	NULL
¢	NULL
.	NULL

The	NULL
consequences	NULL
of	NULL
p80°	NULL
``	NULL
``	NULL
tyrosine	NULL
phosphorylation	NULL
are	NULL
not	NULL
yet	NULL
known	NULL
;	NULL
however	NULL
,	NULL
tyrosine-phosphorylated	NULL
p80°	NULL
``	NULL
``	NULL
is	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
DNA	NULL
,	NULL
and	NULL
G-CSF	NULL
stimulation	NULL
results	NULL
in	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
p80°	NULL
``	NULL
``	NULL
which	NULL
binds	NULL
to	NULL
DNA	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
one	NULL
of	NULL
the	NULL
first	NULL
biochemical	NULL
events	NULL
which	NULL
occurs	NULL
in	NULL
neutrophils	NULL
following	NULL
G-CSF	NULL
stimulation	NULL
,	NULL
activation	NULL
of	NULL
a	NULL
tyrosine	NULL
kinase	NULL
,	NULL
leads	NULL
directly	NULL
to	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p80°	NULL
``	NULL
``	NULL
``	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
tyrosine	NULL
kinase	NULL
activated	NULL
by	NULL
G-CSF	NULL
appears	NULL
to	NULL
directly	NULL
transduce	NULL
a	NULL
signal	NULL
to	NULL
a	NULL
protein	NULL
which	NULL
functions	NULL
as	NULL
a	NULL
transcriptional	NULL
regulator	NULL
.	NULL

Granulocyte-colony	NULL
stimulating	NULL
factor	NULL
(	NULL
G-CSF	NULL
)	NULL
has	NULL
diverse	NULL
effects	NULL
on	NULL
the	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
function	NULL
of	NULL
mature	NULL
neutrophils	NULL
and	NULL
their	NULL
precursors	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

These	NULL
biologic	NULL
ef-	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
CAO1422	NULL
(	NULL
to	NULL
B.J	NULL
.	NULL

D.	NULL
)	NULL
,	NULL
CAS6167	NULL
and	NULL
CAS4183	NULL
(	NULL
to	NULL
J	NULL
.	NULL

D.G	NULL
.	NULL
)	NULL

,	NULL
and	NULL
CA32028	NULL
and	NULL
CA40512	NULL
(	NULL
to	NULL
B.	NULL
R.	NULL
F.	NULL
)	NULL
and	NULL
by	NULL
Sandoz	NULL
Pharmaceuticals	NULL
(	NULL
to	NULL
J.	NULL
D.	NULL
G.	NULL
and	NULL
B.	NULL
J.	NULL
D.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Div	NULL
.	NULL

of	NULL
Hematology	NULL
and	NULL
Medical	NULL
Oncology	NULL
,	NULL
L586	NULL
,	NULL
Oregon	NULL
Health	NULL
Sciences	NULL
University	NULL
,	NULL
3181	NULL
S.	NULL
W.	NULL
Sam	NULL
Jackson	NULL
Park	NULL
Rd	NULL
.	NULL

,	NULL
Portland	NULL
,	NULL
OR	NULL
97201	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
503-494-5596	NULL
;	NULL
Fax	NULL
:	NULL
503-494-7086	NULL
.	NULL

|	NULL
Sponsored	NULL
by	NULL
a	NULL
fellowship	NULL
for	NULL
AIDS	NULL
research	NULL
of	NULL
the	NULL
German	NULL
Cancer	NULL
Research	NULL
Center	NULL
.	NULL
'	NULL

The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
G-CSF	NULL
,	NULL
granulocyte-colony	NULL
stimulating	NULL
factor	NULL
;	NULL
GM	NULL
,	NULL
granulocyte-macrophage	NULL
;	NULL
DNAP	NULL
,	NULL
DNA	NULL
affinity	NULL
precipita-tion	NULL
.	NULL

fects	NULL
are	NULL
mediated	NULL
through	NULL
binding	NULL
of	NULL
G-CSF	NULL
to	NULL
a	NULL
specific	NULL
,	NULL
high	NULL
affinity	NULL
cell	NULL
surface	NULL
receptor	NULL
.	NULL

The	NULL
human	NULL
G-CSF	NULL
receptor	NULL
is	NULL
a	NULL
glycoprotein	NULL
of	NULL
relative	NULL
molecular	NULL
mass	NULL
100-130	NULL
kDa	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Ho-modimerization	NULL
of	NULL
the	NULL
receptor	NULL
is	NULL
believed	NULL
to	NULL
be	NULL
necessary	NULL
to	NULL
create	NULL
a	NULL
high	NULL
affinity	NULL
binding	NULL
site	NULL
for	NULL
G-CSF	NULL
(	NULL
5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
post-receptor	NULL
signal	NULL
transduction	NULL
mechanisms	NULL
remain	NULL
largely	NULL
unknown	NULL
.	NULL

Although	NULL
the	NULL
G-CSF	NULL
receptor	NULL
does	NULL
not	NULL
possess	NULL
intrinsic	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
,	NULL
one	NULL
of	NULL
the	NULL
earliest	NULL
events	NULL
following	NULL
G-CSF	NULL
binding	NULL
to	NULL
its	NULL
receptor	NULL
is	NULL
the	NULL
induction	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
at	NULL
least	NULL
one	NULL
and	NULL
possibly	NULL
several	NULL
intracellular	NULL
proteins	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
proteins	NULL
which	NULL
become	NULL
tyrosine-phosphorylated	NULL
following	NULL
stimw.lation	NULL
of	NULL
neutrophils	NULL
with	NULL
G-CSF	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
important	NULL
in	NULL
understanding	NULL
the	NULL
signal	NULL
transduction	NULL
pathways	NULL
required	NULL
for	NULL
neutrophil	NULL
function	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
the	NULL
major	NULL
protein	NULL
which	NULL
is	NULL
inducibly	NULL
tyrosine-phosphorylated	NULL
following	NULL
treatment	NULL
of	NULL
neutrophils	NULL
with	NULL
G-CSF	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
p80°	NULL
``	NULL
.	NULL

The	NULL
p80°	NULL
``	NULL
*	NULL
``	NULL
protein	NULL
is	NULL
encoded	NULL
for	NULL
by	NULL
a	NULL
proto-oncogene	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
which	NULL
belongs	NULL
to	NULL
a	NULL
family	NULL
of	NULL
transcriptional	NULL
regulatory	NULL
proteins	NULL
which	NULL
include	NULL
v-re/	NULL
,	NULL
the	NULL
oncogene	NULL
product	NULL
of	NULL
the	NULL
avian	NULL
reticuloendotheliosis	NULL
virus	NULL
strain	NULL
T	NULL
(	NULL
rev-T	NULL
)	NULL
(	NULL
9	NULL
)	NULL
,	NULL
the	NULL
maternal	NULL
effects	NULL
gene	NULL
dorsal	NULL
of	NULL
Drosophila	NULL
(	NULL
10-12	NULL
)	NULL
,	NULL
and	NULL
the	NULL
ubiquitous	NULL
factor	NULL
NF-kB	NULL
(	NULL
13-15	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
one	NULL
of	NULL
the	NULL
first	NULL
biochemical	NULL
events	NULL
which	NULL
occurs	NULL
in	NULL
neutrophils	NULL
following	NULL
G-CSF	NULL
stimulation	NULL
,	NULL
activation	NULL
of	NULL
a	NULL
tyrosine	NULL
kinase	NULL
,	NULL
leads	NULL
directly	NULL
and	NULL
rapidly	NULL
to	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p80°	NULL
``	NULL
``	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
tyrosine	NULL
kinase	NULL
activated	NULL
by	NULL
G-CSF	NULL
appears	NULL
to	NULL
directly	NULL
transduce	NULL
a	NULL
signal	NULL
to	NULL
a	NULL
protein	NULL
which	NULL
functions	NULL
as	NULL
a	NULL
transcriptional	NULL
regulator	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents-Highly	NULL
purified	NULL
recombinant	NULL
human	NULL
G-CSF	NULL
and	NULL
GM-CSF	NULL
were	NULL
gifts	NULL
of	NULL
Dr.	NULL
Steven	NULL
Clark	NULL
and	NULL
Gordon	NULL
Wong	NULL
,	NULL
Genetics	NULL
Institute	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
.	NULL

Endotoxin	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
,	NULL
platelet	NULL
activating	NULL
factor	NULL
,	NULL
CSa	NULL
,	NULL
fMet-Leu-Phe	NULL
,	NULL
and	NULL
phorbol	NULL
ester	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

Antisera-The	NULL
antiphosphotyrosine	NULL
antibody	NULL
4G10	NULL
was	NULL
generated	NULL
using	NULL
phosphotyramine	NULL
as	NULL
the	NULL
immunogen	NULL
and	NULL
was	NULL
used	NULL
as	NULL
described	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
rel	NULL
antiserum	NULL
is	NULL
a	NULL
polyclonal	NULL
rabbit	NULL
antiserum	NULL
prepared	NULL
against	NULL
a	NULL
synthetic	NULL
peptide	NULL
corresponding	NULL
to	NULL
the	NULL
unique	NULL
carboxyl-ter-minal	NULL
16	NULL
amino	NULL
acids	NULL
of	NULL
human	NULL
p80	NULL
%	NULL
*	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
Human	NULL
Neutrophils-Normal	NULL
peripheral	NULL
blood	NULL
was	NULL
obtained	NULL
from	NULL
healthy	NULL
adult	NULL
volunteers	NULL
and	NULL
fractionated	NULL
on	NULL
a	NULL
Ficoll-Hypaque	NULL
density	NULL
step	NULL
gradient	NULL
(	NULL
1.077	NULL
g/ml	NULL
)	NULL
.	NULL

The	NULL
pellet	NULL
was	NULL
washed	NULL
twice	NULL
with	NULL
Hanks	NULL
'	NULL
balanced	NULL
salt	NULL
solution	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

Red	NULL
blood	NULL
cells	NULL
were	NULL
lysed	NULL
by	NULL
incubation	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
in	NULL
ammonium	NULL
chloride	NULL
(	NULL
8.29	NULL
g/liter	NULL
,	NULL
pH	NULL
7.27	NULL
)	NULL
.	NULL

The	NULL
neutrophil	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
containing	NULL
0.5	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
Fraction	NULL
V	NULL
(	NULL
Sigma	NULL
)	NULL
at	NULL
5	NULL
x	NULL
10°	NULL
cells/ml	NULL
.	NULL

Stimulation	NULL
with	NULL
Factors	NULL
and	NULL
Cell	NULL
Lysis-Neutrophils	NULL
were	NULL
pre-treated	NULL
with	NULL
1	NULL
mm	NULL
diisopropyl	NULL
fluorophosphate	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
to	NULL
inhibit	NULL
proteases	NULL
before	NULL
factor	NULL
stimulation	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
5387	NULL
5388	NULL
warmed	NULL
to	NULL
37	NULL
°C	NULL
and	NULL
treated	NULL
with	NULL
G-CSF	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10	NULL
ng/ml	NULL
for	NULL
0-60	NULL
min	NULL
.	NULL

Other	NULL
factors	NULL
and	NULL
concentrations	NULL
used	NULL
for	NULL
stimulation	NULL
were	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

,	NULL
endotoxin	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
,	NULL
platelet-activating	NULL
factor	NULL
(	NULL
10-8	NULL
m	NULL
)	NULL
,	NULL
C5a	NULL
(	NULL
10-	NULL
'	NULL
m	NULL
)	NULL
,	NULL
fMet-Leu-Phe	NULL
(	NULL
10-	NULL
'	NULL
m	NULL
)	NULL
,	NULL
and	NULL
phorbol	NULL
ester	NULL
(	NULL
10-°	NULL
m	NULL
)	NULL
.	NULL

Following	NULL
stimulation	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
lysed	NULL
in	NULL
lysis	NULL
buffer	NULL
(	NULL
20	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
150	NULL
mm	NULL
NaCl	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
)	NULL
containing	NULL
1	NULL
mm	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
0.15	NULL
unit/ml	NULL
aprotinin	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
10	NULL
ug/ml	NULL
leupeptin	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
and	NULL
1	NULL
mm	NULL
sodium	NULL
ortho-vanadate	NULL
(	NULL
Sigma	NULL
)	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
20	NULL
min	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10°	NULL
cells/ml	NULL
.	NULL

Insoluble	NULL
material	NULL
was	NULL
removed	NULL
by	NULL
centrifugation	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
10	NULL
min	NULL
at	NULL
10,000	NULL
x	NULL
g.	NULL
Alternatively	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
DNA	NULL
affinity	NULL
precipitation	NULL
buffer	NULL
as	NULL
described	NULL
below	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
we	NULL
have	NULL
compared	NULL
lysates	NULL
prepared	NULL
by	NULL
boiling	NULL
in	NULL
SDS	NULL
to	NULL
lysates	NULL
made	NULL
in	NULL
NP40	NULL
with	NULL
and	NULL
without	NULL
EDTA	NULL
and	NULL
have	NULL
found	NULL
no	NULL
significant	NULL
differences	NULL
in	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
.	NULL

Immunoprecipitations	NULL
,	NULL
Gel	NULL
Electrophoresis	NULL
,	NULL
and	NULL
Immunoblotting-Whole	NULL
cell	NULL
lysates	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
mixed	NULL
1:1	NULL
with	NULL
2	NULL
x	NULL
SDS	NULL
buffer	NULL
(	NULL
19	NULL
)	NULL
with	NULL
2-mereaptoethanol	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
and	NULL
heated	NULL
at	NULL
95	NULL
°C	NULL
for	NULL
3	NULL
min	NULL
prior	NULL
to	NULL
one-dimensional	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
with	NULL
7.5	NULL
%	NULL
polyacrylamide	NULL
.	NULL

For	NULL
immunoprecipitations	NULL
,	NULL
lysates	NULL
containing	NULL
1	NULL
x	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
20	NULL
ul	NULL
of	NULL
4G10	NULL
cross-linked	NULL
to	NULL
Protein	NULL
A-Sepharose	NULL
(	NULL
Pharmacia	NULL
LKB	NULL
Biotechnolgy	NULL
Inc.	NULL
)	NULL
at	NULL
2	NULL
mg/ml	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
20	NULL
)	NULL
or	NULL
5	NULL
ul	NULL
of	NULL
polyclonal	NULL
p80°	NULL
'	NULL
``	NULL
antiserum	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
4	NULL
h.	NULL
Anti-rel	NULL
immune	NULL
complexes	NULL
were	NULL
collected	NULL
by	NULL
incubation	NULL
with	NULL
25	NULL
ul	NULL
of	NULL
Protein	NULL
A-Sepharose	NULL
for	NULL
an	NULL
additional	NULL
30	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
lysis	NULL
buffer	NULL
,	NULL
twice	NULL
with	NULL
0.5	NULL
m	NULL
LiCl	NULL
,	NULL
20	NULL
ma	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
and	NULL
once	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
.	NULL

Washed	NULL
immunoprecipitates	NULL
were	NULL
resuspended	NULL
in	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
water	NULL
,	NULL
then	NULL
mixed	NULL
with	NULL
sample	NULL
buffer	NULL
and	NULL
treated	NULL
as	NULL
described	NULL
above	NULL
prior	NULL
to	NULL
gel	NULL
electrophoresis	NULL
.	NULL

After	NULL
electrophoresis	NULL
,	NULL
proteins	NULL
were	NULL
electrophoretically	NULL
transferred	NULL
to	NULL
0.2-um	NULL
nitrocellulose	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
)	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
25	NULL
mm	NULL
Tris	NULL
,	NULL
192	NULL
mi	NULL
glycine	NULL
,	NULL
and	NULL
20	NULL
%	NULL
methanol	NULL
at	NULL
0.4	NULL
A	NULL
for	NULL
4	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Residual	NULL
binding	NULL
sites	NULL
were	NULL
blocked	NULL
by	NULL
incubation	NULL
in	NULL
TBS	NULL
(	NULL
10	NULL
mm	NULL
Tris	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
150	NULL
mm	NULL
NaCl	NULL
)	NULL
containing	NULL
2	NULL
%	NULL
gelatin	NULL
for	NULL
60	NULL
min	NULL
at	NULL
25	NULL
°C	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
incubated	NULL
overnight	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
antiphosphotyrosine	NULL
antibody	NULL
(	NULL
1.5	NULL
ug/ml	NULL
)	NULL
or	NULL
for	NULL
2	NULL
h	NULL
with	NULL
rel	NULL
antiserum	NULL
diluted	NULL
1:1000	NULL
in	NULL
TBST	NULL
(	NULL
TBS	NULL
with	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
.	NULL

Antibody	NULL
reactions	NULL
were	NULL
detected	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
16	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Prestained	NULL
molecular	NULL
weight	NULL
markers	NULL
were	NULL
run	NULL
on	NULL
each	NULL
gel	NULL
and	NULL
were	NULL
obtained	NULL
from	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
DNA	NULL
Affinity	NULL
Precipitation	NULL
(	NULL
DNAP	NULL
)	NULL
Assay-Human	NULL
neutrophils	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
)	NULL
either	NULL
untreated	NULL
or	NULL
stimulated	NULL
with	NULL
G-CSF	NULL
were	NULL
lysed	NULL
twice	NULL
in	NULL
600	NULL
ul	NULL
of	NULL
DNAP	NULL
buffer	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Dithiothreitol	NULL
(	NULL
final	NULL
concentration	NULL
1	NULL
mm	NULL
)	NULL
,	NULL
phenylmethylsulfony	NULL
]	NULL
fluoride	NULL
(	NULL
1	NULL
mm	NULL
)	NULL
,	NULL
leupeptin	NULL
(	NULL
10	NULL
mm/m	NULL
!	NULL
)	NULL

,	NULL
and	NULL
phenyl	NULL
arsine	NULL
oxide	NULL
(	NULL
37	NULL
um	NULL
)	NULL
were	NULL
added	NULL
immediately	NULL
before	NULL
use	NULL
.	NULL

The	NULL
final	NULL
potassium	NULL
chloride	NULL
(	NULL
KCI	NULL
)	NULL
concentration	NULL
was	NULL
250	NULL
max	NULL
for	NULL
the	NULL
extraction	NULL
and	NULL
50	NULL
mx	NULL
for	NULL
the	NULL
binding	NULL
assay	NULL
.	NULL

The	NULL
final	NULL
sodium	NULL
fluoride	NULL
(	NULL
NaF	NULL
)	NULL
concentration	NULL
was	NULL
50	NULL
mm	NULL
.	NULL

A	NULL
40-fold	NULL
excess	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
)	NULL
was	NULL
used	NULL
per	NULL
DNAP	NULL
assay	NULL
.	NULL

The	NULL
binding	NULL
reaction	NULL
was	NULL
performed	NULL
with	NULL
100	NULL
pmol	NULL
of	NULL
biotinylated	NULL
oligonucleotide	NULL
.	NULL

The	NULL
oligonucleotides	NULL
were	NULL
synthesized	NULL
by	NULL
ISIS	NULL
Pharmaceuticals	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
.	NULL

The	NULL
oligonucleotides	NULL
were	NULL
synthesized	NULL
with	NULL
a	NULL
3	NULL
'	NULL
end	NULL
biotin	NULL
group	NULL
and	NULL
had	NULL
a	NULL
phosphothiorate	NULL
backbone	NULL
rendering	NULL
them	NULL
nuclease	NULL
insensitive	NULL
.	NULL

They	NULL
were	NULL
otherwise	NULL
identical	NULL
to	NULL
previously	NULL
reported	NULL
HIV-1	NULL
kB	NULL
wild	NULL
type	NULL
and	NULL
mutant	NULL
oligonucleotides	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
biotinylated	NULL
oligonucleotide-protein	NULL
complexes	NULL
recovered	NULL
by	NULL
binding	NULL
to	NULL
streptavidin-agarose	NULL
beads	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
with	NULL
400	NULL
ul	NULL
of	NULL
DNAP	NULL
buffer	NULL
containing	NULL
50	NULL
mm	NULL
NaF	NULL
and	NULL
75	NULL
mm	NULL
KCl	NULL
.	NULL

A	NULL
DNase/RNase	NULL
digest	NULL
was	NULL
performed	NULL
for	NULL
2	NULL
min	NULL
on	NULL
ice	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
complexes	NULL
were	NULL
heated	NULL
for	NULL
3	NULL
min	NULL
at	NULL
95	NULL
°C	NULL
in	NULL
Laemmli	NULL
sample	NULL
buffer	NULL
(	NULL
50	NULL
ul/pellet	NULL
)	NULL
(	NULL
19	NULL
)	NULL
and	NULL
were	NULL
subjected	NULL
to	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Proteins	NULL
were	NULL
electrophoretically	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
and	NULL
detected	NULL
by	NULL
immunoblotting	NULL
as	NULL
described	NULL
above	NULL
.	NULL

RESULTS	NULL
G-CSF	NULL
Induces	NULL
Tyrosine	NULL
Phosphorylation	NULL
of	NULL
an	NULL
80-kDa	NULL
Protein	NULL
in	NULL
Human	NULL
Neutrophils-Human	NULL
neutrophils	NULL
stimulated	NULL
with	NULL
G-CSF	NULL
were	NULL
evaluated	NULL
by	NULL
immunoblotting	NULL
with	NULL
an	NULL
antiphosphotyrosine	NULL
antibody	NULL
in	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
G-CSF	NULL
receptor	NULL
stimulation	NULL
results	NULL
in	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
any	NULL
novel	NULL
intracellular	NULL
proteins	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
the	NULL
pattern	NULL
of	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
seen	NULL
following	NULL
G-CSF	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
was	NULL
relatively	NULL
simple	NULL
.	NULL

The	NULL
major	NULL
change	NULL
was	NULL
the	NULL
inducible	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
protein	NULL
of	NULL
relative	NULL
molecular	NULL
mass	NULL
of	NULL
80	NULL
kDa	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
this	NULL
80-kDa	NULL
protein	NULL
could	NULL
be	NULL
seen	NULL
G-CSF	NULL
Stimulates	NULL
Tyrosine	NULL
Phosphorylation	NULL
of	NULL
rel	NULL
-	NULL
G	NULL
200	NULL
116	NULL
80	NULL
_-	NULL
49	NULL
|	NULL
n	NULL
Inne	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Identification	NULL
of	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
in	NULL
human	NULL
neutrophils	NULL
after	NULL
stimulation	NULL
with	NULL
G-CSF	NULL
.	NULL

Neutrophils	NULL
prepared	NULL
from	NULL
fresh	NULL
heparinized	NULL
blood	NULL
were	NULL
treated	NULL
with	NULL
G-CSF	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
for	NULL
15	NULL
min	NULL
prior	NULL
to	NULL
lysis	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Changes	NULL
in	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
were	NULL
detected	NULL
by	NULL
immunoblotting	NULL
with	NULL
a	NULL
monoclonal	NULL
antiphosphotyrosine	NULL
antibody	NULL
.	NULL

Molecular	NULL
mass	NULL
markers	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
in	NULL
kilodaltons	NULL
.	NULL

as	NULL
early	NULL
as	NULL
5	NULL
min	NULL
following	NULL
G-CSF	NULL
treatment	NULL
of	NULL
neutrophils	NULL
and	NULL
remained	NULL
relatively	NULL
constant	NULL
when	NULL
examined	NULL
in	NULL
a	NULL
1-h	NULL
time	NULL
course	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Tyrosine	NULL
Phosphorylation	NULL
of	NULL
the	NULL
80-kDa	NULL
Protein	NULL
Is	NULL
Specific	NULL
to	NULL
Stimulation	NULL
of	NULL
Neutrophils	NULL
with	NULL
G-CSF-Signal	NULL
transduction	NULL
through	NULL
receptor	NULL
linked	NULL
tyrosine	NULL
kinases	NULL
is	NULL
a	NULL
relatively	NULL
common	NULL
phenomenon	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
pattern	NULL
of	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
obtained	NULL
following	NULL
G-CSF	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
was	NULL
compared	NULL
to	NULL
that	NULL
obtained	NULL
following	NULL
treatment	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
other	NULL
factors	NULL
known	NULL
to	NULL
stimulate	NULL
neutrophil	NULL
function	NULL
.	NULL

Treatment	NULL
of	NULL
neutrophils	NULL
with	NULL
GM-CSF	NULL
resulted	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
proteins	NULL
of	NULL
130	NULL
,	NULL
93	NULL
,	NULL
70	NULL
,	NULL
and	NULL
42	NULL
kDa	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
16	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
phorbol	NULL
ester	NULL
stimulation	NULL
resulted	NULL
in	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
42-kDa	NULL
protein	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
MAP-2	NULL
kinase	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Other	NULL
factors	NULL
for	NULL
which	NULL
neutrophils	NULL
contain	NULL
receptors	NULL
,	NULL
such	NULL
as	NULL
endotoxin	NULL
,	NULL
C5a	NULL
,	NULL
tissue	NULL
necrosis	NULL
factor	NULL
,	NULL
and	NULL
fMet-Leu-Phe	NULL
failed	NULL
to	NULL
result	NULL
in	NULL
any	NULL
discernible	NULL
changes	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
at	NULL
the	NULL
time	NULL
point	NULL
chosen	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
80-kDa	NULL
protein	NULL
following	NULL
G-CSF	NULL
stimulation	NULL
appears	NULL
to	NULL
be	NULL
specific	NULL
to	NULL
the	NULL
G-CSF	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

The	NULL
80-kDa	NULL
Tyrosine-phosphorylated	NULL
Protein	NULL
Is	NULL
p80°	NULL
%	NULL
'	NULL
``	NULL
-Previous	NULL
reports	NULL
have	NULL
shown	NULL
p80®	NULL
'	NULL
``	NULL
to	NULL
be	NULL
inducibly	NULL
tyrosine-phosphorylated	NULL
in	NULL
T	NULL
cells	NULL
following	NULL
stimulation	NULL
with	NULL
phytohe-magglutinin	NULL
and	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Given	NULL
this	NULL
finding	NULL
,	NULL
a	NULL
rel-specific	NULL
antiserum	NULL
was	NULL
employed	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
80-kDa	NULL
tyrosine-phosphorylated	NULL
protein	NULL
seen	NULL
following	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
with	NULL
G-CSF	NULL
was	NULL
p80¢	NULL
'	NULL
``	NULL
``	NULL
.	NULL

In	NULL
unstimulated	NULL
neutrophils	NULL
,	NULL
no	NULL
detectable	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p80¢	NULL
``	NULL
``	NULL
could	NULL
be	NULL
detected	NULL
.	NULL

However	NULL
,	NULL
G-CSF	NULL
treatment	NULL
of	NULL
neutrophils	NULL
resulted	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
80-kDa	NULL
protein	NULL
which	NULL
can	NULL
be	NULL
detected	NULL
in	NULL
anti-rel	NULL
immunoprecipitates	NULL
followed	NULL
by	NULL
antiphosphotyrosine	NULL
immunoblotting	NULL
or	NULL
by	NULL
antiphosphotyrosine	NULL
immunoprecipitates	NULL
followed	NULL
by	NULL
anti-rel	NULL
immunoblotting	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Similar	NULL
amounts	NULL
of	NULL
p80	NULL
could	NULL
be	NULL
immunoprecipitated	NULL
from	NULL
control	NULL
and	NULL
factor-treated	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Serial	NULL
immunoprecipitations	NULL
demonstrate	NULL
that	NULL
approximately	NULL
5-10	NULL
%	NULL
of	NULL
total	NULL
cellular	NULL
p80	NULL
``	NULL
is	NULL
inducibly	NULL
tyrosine-phosphorylated	NULL
and	NULL
that	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
tyrosine-phosphorylated	NULL
80-kDa	NULL
protein	NULL
can	NULL
be	NULL
depleted	NULL
with	NULL
rel	NULL
antiserum	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
p80°	NULL
``	NULL
appears	NULL
to	NULL
account	NULL
for	NULL
most	NULL
of	NULL
the	NULL
80-kDa	NULL
tyrosine-phosphorylated	NULL
protein	NULL
seen	NULL
in	NULL
neutrophils	NULL
following	NULL
G-CSF	NULL
stimulation	NULL
.	NULL

G-CSF	NULL
Stimulates	NULL
Tyrosine	NULL
Phosphorylation	NULL
of	NULL
rel	NULL
5	NULL
15	NULL
30	NULL
60	NULL
``	NULL
*	NULL
whe	NULL
whet	NULL
MBk	NULL
%	NULL
Ko-	NULL
ph	NULL
P	NULL
ﬂ	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
following	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
with	NULL
G-CSF	NULL
.	NULL

Human	NULL
neutrophils	NULL
prepared	NULL
from	NULL
fresh	NULL
heparinized	NULL
blood	NULL
were	NULL
treated	NULL
for	NULL
various	NULL
times	NULL
with	NULL
G-CSF	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
and	NULL
analyzed	NULL
for	NULL
changes	NULL
in	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
by	NULL
immunoblotting	NULL
with	NULL
a	NULL
monoclonal	NULL
antiphosphotyrosine	NULL
antibody	NULL
.	NULL

Time	NULL
is	NULL
indicated	NULL
in	NULL
minutes	NULL
along	NULL
the	NULL
top	NULL
of	NULL
the	NULL
panel	NULL
.	NULL

Molecular	NULL
mass	NULL
markers	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
in	NULL
kilodaltons	NULL
.	NULL

-	NULL
G-	NULL
GM	NULL
ET	NULL
TNF	NULL
PAF	NULL
CSa	NULL
fMLP	NULL
PMA	NULL
200	NULL
h	NULL
alea	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
p80	NULL
is	NULL
specific	NULL
to	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
with	NULL
G-CSF	NULL
.	NULL

Freshly	NULL
prepared	NULL
human	NULL
neutrophils	NULL
were	NULL
stimulated	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
factors	NULL
for	NULL
10	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
.	NULL

Lysates	NULL
were	NULL
analyzed	NULL
for	NULL
changes	NULL
in	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
by	NULL
immunoblotting	NULL
with	NULL
a	NULL
monoclonal	NULL
antiphosphotyrosine	NULL
antibody	NULL
.	NULL

Abbreviations	NULL
:	NULL
G	NULL
,	NULL
G-CSF	NULL
;	NULL
GM	NULL
,	NULL
GM-CSF	NULL
;	NULL
ET	NULL
,	NULL
endotoxin	NULL
;	NULL
TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
;	NULL
PAF	NULL
,	NULL
platelet-activating	NULL
factor	NULL
;	NULL
fMLP	NULL
,	NULL
fMet-Leu-Phe	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
.	NULL

Molecular	NULL
mass	NULL
markers	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
in	NULL
kilodaltons	NULL
.	NULL

G-CSF	NULL
Treatment	NULL
of	NULL
Neutrophils	NULL
Results	NULL
in	NULL
an	NULL
Increase	NULL
in	NULL
DNA	NULL
Binding	NULL
of	NULL
p80°	NULL
``	NULL
``	NULL
-Nuclear	NULL
lysates	NULL
of	NULL
untreated	NULL
and	NULL
factor	NULL
treated	NULL
neutrophils	NULL
were	NULL
examined	NULL
in	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
G-CSF	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p80¢	NULL
``	NULL
``	NULL
resulted	NULL
in	NULL
any	NULL
alteration	NULL
in	NULL
DNA	NULL
binding	NULL
of	NULL
p80	NULL
``	NULL
.	NULL

G-CSF	NULL
treatment	NULL
of	NULL
neutrophils	NULL
results	NULL
in	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
p80°¢	NULL
``	NULL
``	NULL
which	NULL
is	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
an	NULL
HIV-1	NULL
kB	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
rel	NULL
immunoblot	NULL
)	NULL
.	NULL

Tyrosine-phosphorylated	NULL
p80	NULL
``	NULL
is	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
DNA	NULL
and	NULL
most	NULL
of	NULL
the	NULL
increase	NULL
in	NULL
p80°	NULL
'	NULL
``	NULL
bound	NULL
to	NULL
DNA	NULL
can	NULL
be	NULL
accounted	NULL
for	NULL
by	NULL
the	NULL
tyrosine-phosphorylated	NULL
form	NULL
of	NULL
p80°¢'*	NULL
``	NULL
.	NULL

A	NULL
small	NULL
amount	NULL
of	NULL
tyrosine-phosphorylated	NULL
p80¢®	NULL
``	NULL
``	NULL
was	NULL
detected	NULL
in	NULL
unstimulated	NULL
neutrophils	NULL
;	NULL
however	NULL
,	NULL
this	NULL
is	NULL
comparable	NULL
to	NULL
the	NULL
background	NULL
tyrosine	NULL
phosphorylation	NULL
observed	NULL
in	NULL
immunoblots	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

DISCUSSION	NULL
The	NULL
results	NULL
presented	NULL
here	NULL
demonstrate	NULL
that	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
with	NULL
G-CSF	NULL
results	NULL
in	NULL
the	NULL
rapid	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p80¢	NULL
'	NULL
``	NULL
.	NULL

G-CSF	NULL
treatment	NULL
of	NULL
neutrophils	NULL
not	NULL
only	NULL
results	NULL
in	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p80	NULL
``	NULL
but	NULL
results	NULL
in	NULL
5389	NULL
A	NULL
_	NULL
ReLLP	NULL
.	NULL

B	NULL
P-tyr	NULL
I.	NULL
P.	NULL
P-Tyr	NULL
Blot	NULL
Rel	NULL
Blot	NULL
-	NULL
G	NULL
GM	NULL
=-	NULL
G	NULL
GM	NULL
200	NULL
116	NULL
|	NULL
80	NULL
-	NULL
<	NULL
-	NULL
p80	NULL
-	NULL
»	NULL
Shim	NULL
49	NULL
”	NULL
ﬁ	NULL
'	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
80-kDa	NULL
tyrosine	NULL
phosphorylated	NULL
protein	NULL
as	NULL
p80®	NULL
``	NULL
*	NULL
``	NULL
.	NULL

Freshly	NULL
prepared	NULL
human	NULL
neutrophils	NULL
(	NULL
1	NULL
x	NULL
10	NULL
``	NULL
cells/lane	NULL
)	NULL
were	NULL
treated	NULL
with	NULL
G-CSF	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
or	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
prior	NULL
to	NULL
lysis	NULL
.	NULL

Lysates	NULL
were	NULL
either	NULL
(	NULL
A	NULL
)	NULL
immunoprecipitated	NULL
with	NULL
rel	NULL
antisera	NULL
prior	NULL
to	NULL
gel	NULL
electrophoresis	NULL
and	NULL
immunoblotted	NULL
with	NULL
a	NULL
monoclonal	NULL
antiphosphotyrosine	NULL
antibody	NULL
or	NULL
(	NULL
B	NULL
)	NULL
immunoprecipitated	NULL
with	NULL
antiphosphotyrosine	NULL
antibodies	NULL
followed	NULL
by	NULL
immunoblotting	NULL
with	NULL
rel	NULL
antisera	NULL
.	NULL

The	NULL
migration	NULL
of	NULL
p80°'*	NULL
``	NULL
is	NULL
marked	NULL
with	NULL
an	NULL
arrow	NULL
.	NULL

Molecular	NULL
mass	NULL
markers	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
in	NULL
kilodaltons	NULL
.	NULL

xB	NULL
DNA	NULL
Affinity	NULL
Precipitation	NULL
Assays	NULL
mutant	NULL
KB	NULL
site	NULL
Normal	NULL
KB	NULL
site	NULL
Anti~PTyr	NULL
Immunoblot	NULL
Rel	NULL
-=	NULL
Anti-Rel	NULL
Immunoblot	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

DNA	NULL
affinity	NULL
precipitation	NULL
of	NULL
p80¢	NULL
``	NULL
``	NULL
following	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
with	NULL
G-CSF	NULL
.	NULL

Neutrophils	NULL
(	NULL
1	NULL
x	NULL
10®/lane	NULL
)	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
G-CSF	NULL
were	NULL
prepared	NULL
and	NULL
lysed	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Nuclear	NULL
lysates	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
wild	NULL
type	NULL
or	NULL
mutant	NULL
kB	NULL
site	NULL
.	NULL

Bound	NULL
proteins	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
followed	NULL
by	NULL
immunoblotting	NULL
with	NULL
antiphosphotyrosine	NULL
antibodies	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
or	NULL
rel	NULL
antisera	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
migration	NULL
of	NULL
p80°	NULL
``	NULL
*	NULL
'	NULL
is	NULL
marked	NULL
with	NULL
an	NULL
arrow	NULL
.	NULL

This	NULL
experiment	NULL
has	NULL
been	NULL
performed	NULL
seven	NULL
times	NULL
,	NULL
each	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

an	NULL
increase	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
p80°	NULL
``	NULL
*	NULL
``	NULL
which	NULL
is	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
a	NULL
kB	NULL
site	NULL
.	NULL

Most	NULL
of	NULL
this	NULL
increase	NULL
can	NULL
be	NULL
accounted	NULL
for	NULL
by	NULL
the	NULL
tyrosine-phosphorylated	NULL
p80¢	NULL
'	NULL
``	NULL
species	NULL
.	NULL

The	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p80¢	NULL
``	NULL
``	NULL
is	NULL
specific	NULL
to	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
with	NULL
G-CSF	NULL
.	NULL

Although	NULL
GM-CSF	NULL
is	NULL
similar	NULL
to	NULL
G-CSF	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
stimulate	NULL
the	NULL
function	NULL
of	NULL
neutrophils	NULL
for	NULL
tumor	NULL
cell	NULL
killing	NULL
and	NULL
an	NULL
enhanced	NULL
respiratory	NULL
burst	NULL
,	NULL
the	NULL
proteins	NULL
which	NULL
become	NULL
tyrosine-phosphorylated	NULL
in	NULL
neutrophils	NULL
following	NULL
GM-CSF	NULL
treatment	NULL
are	NULL
different	NULL
than	NULL
those	NULL
seen	NULL
inducibly	NULL
phosphorylated	NULL
after	NULL
G-CSF	NULL
treatment	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
different	NULL
kinases	NULL
become	NULL
activated	NULL
following	NULL
binding	NULL
of	NULL
ligand	NULL
to	NULL
their	NULL
cognate	NULL
receptors	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
same	NULL
kinase	NULL
could	NULL
have	NULL
differing	NULL
substrate	NULL
specificity	NULL
depending	NULL
on	NULL
the	NULL
manner	NULL
in	NULL
which	NULL
it	NULL
is	NULL
activated	NULL
.	NULL

These	NULL
data	NULL
also	NULL
suggest	NULL
that	NULL
the	NULL
tyrosine	NULL
kinase	NULL
pathway	NULL
of	NULL
signal	NULL
transduction	NULL
utilized	NULL
by	NULL
G-and	NULL
GM-CSF	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
unique	NULL
5390	NULL
effects	NULL
of	NULL
each	NULL
of	NULL
these	NULL
factors	NULL
rather	NULL
than	NULL
for	NULL
their	NULL
overlapping	NULL
functions	NULL
.	NULL

However	NULL
,	NULL
it	NULL
remains	NULL
possible	NULL
that	NULL
these	NULL
two	NULL
pathways	NULL
could	NULL
converge	NULL
on	NULL
common	NULL
downstream	NULL
effectors	NULL
.	NULL

The	NULL
major	NULL
protein	NULL
which	NULL
becomes	NULL
tyrosine-phosphorylated	NULL
following	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
with	NULL
G-CSF	NULL
is	NULL
p80°	NULL
``	NULL
``	NULL
.	NULL

The	NULL
p80°	NULL
``	NULL
*	NULL
``	NULL
protein	NULL
is	NULL
encoded	NULL
for	NULL
by	NULL
a	NULL
proto-oncogene	NULL
which	NULL
belongs	NULL
to	NULL
a	NULL
family	NULL
of	NULL
transcriptional	NULL
regulatory	NULL
proteins	NULL
which	NULL
include	NULL
v-re/	NULL
,	NULL
the	NULL
oncogene	NULL
product	NULL
of	NULL
the	NULL
avian	NULL
reticuloendotheliosis	NULL
virus	NULL
strain	NULL
T	NULL
(	NULL
rev-T	NULL
)	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Other	NULL
members	NULL
of	NULL
this	NULL
family	NULL
include	NULL
the	NULL
maternal	NULL
effects	NULL
gene	NULL
dorsal	NULL
of	NULL
Drosophila	NULL
which	NULL
has	NULL
a	NULL
role	NULL
in	NULL
the	NULL
establishment	NULL
of	NULL
dorsal/ventral	NULL
polarity	NULL
of	NULL
the	NULL
Drosophila	NULL
embryo	NULL
(	NULL
10-12	NULL
)	NULL
.	NULL

Another	NULL
well	NULL
characterized	NULL
member	NULL
of	NULL
this	NULL
family	NULL
is	NULL
the	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
which	NULL
is	NULL
composed	NULL
or	NULL
two	NULL
rel-related	NULL
proteins	NULL
(	NULL
13-15	NULL
)	NULL
.	NULL

NF-kB	NULL
activity	NULL
is	NULL
induced	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
agents	NULL
including	NULL
cytokines	NULL
,	NULL
mitogenic	NULL
lectins	NULL
,	NULL
and	NULL
phorbol	NULL
esters	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

The	NULL
rel	NULL
proteins	NULL
are	NULL
regulated	NULL
in	NULL
part	NULL
by	NULL
subcellular	NULL
localization	NULL
.	NULL

NF-kB	NULL
appears	NULL
to	NULL
be	NULL
sequestered	NULL
in	NULL
an	NULL
inactive	NULL
form	NULL
in	NULL
the	NULL
cytoplasm	NULL
through	NULL
its	NULL
association	NULL
with	NULL
IkB	NULL
which	NULL
in	NULL
turn	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
cyto-skeleton	NULL
by	NULL
virtue	NULL
of	NULL
ankryin	NULL
repeats	NULL
(	NULL
14	NULL
,	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Cellular	NULL
activation	NULL
results	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
IkB	NULL
,	NULL
releasing	NULL
NF-kB	NULL
which	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
where	NULL
it	NULL
can	NULL
bind	NULL
to	NULL
and	NULL
modulate	NULL
the	NULL
transcriptional	NULL
activity	NULL
at	NULL
kB	NULL
sites	NULL
(	NULL
24	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Although	NULL
similar	NULL
interactions	NULL
have	NULL
been	NULL
demonstrated	NULL
for	NULL
p80°	NULL
,	NULL
it	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
that	NULL
p80°	NULL
'	NULL
``	NULL
function	NULL
can	NULL
be	NULL
modified	NULL
directly	NULL
by	NULL
phosphorylation	NULL
of	NULL
p80	NULL
(	NULL
26	NULL
,	NULL
27	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
p80°	NULL
``	NULL
``	NULL
has	NULL
been	NULL
demonstrated	NULL
in	NULL
T	NULL
cells	NULL
following	NULL
stimulation	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
and	NULL
was	NULL
associated	NULL
with	NULL
translocation	NULL
of	NULL
p80¢	NULL
'	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
present	NULL
study	NULL
extends	NULL
these	NULL
findings	NULL
by	NULL
showing	NULL
that	NULL
G-CSF	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
results	NULL
in	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
binding	NULL
of	NULL
tyrosine	NULL
phosphorylated	NULL
p80	NULL
``	NULL
isoforms	NULL
to	NULL
a	NULL
kB	NULL
site	NULL
.	NULL

The	NULL
functional	NULL
consequences	NULL
of	NULL
p80°*	NULL
tyrosine	NULL
phosphorylation	NULL
have	NULL
not	NULL
been	NULL
determined	NULL
.	NULL

As	NULL
the	NULL
increase	NULL
in	NULL
DNA	NULL
binding	NULL
of	NULL
p80°	NULL
``	NULL
``	NULL
could	NULL
be	NULL
accounted	NULL
for	NULL
largely	NULL
by	NULL
the	NULL
tyrosine-phosphorylated	NULL
form	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
results	NULL
directly	NULL
in	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
DNA	NULL
binding	NULL
ability	NULL
of	NULL
Alternatively	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
might	NULL
alter	NULL
the	NULL
ability	NULL
of	NULL
p80¢*	NULL
to	NULL
modulate	NULL
transcriptional	NULL
activity	NULL
of	NULL
specific	NULL
promoters	NULL
or	NULL
may	NULL
regulate	NULL
subcellular	NULL
localization	NULL
of	NULL
p80°	NULL
``	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
here	NULL
implicate	NULL
p80¢	NULL
``	NULL
``	NULL
as	NULL
an	NULL
important	NULL
signal-transducing	NULL
protein	NULL
in	NULL
G-CSF-stimulated	NULL
pathways	NULL
in	NULL
G-CSF	NULL
Stimulates	NULL
Tyrosine	NULL
Phosphorylation	NULL
of	NULL
rel	NULL
neutrophils	NULL
.	NULL

The	NULL
specific	NULL
transcriptional	NULL
program	NULL
modified	NULL
by	NULL
p80¢	NULL
``	NULL
``	NULL
following	NULL
G-CSF	NULL
treatment	NULL
of	NULL
neutrophils	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
as	NULL
does	NULL
the	NULL
kinase	NULL
responsible	NULL
for	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
p80¢	NULL
'	NULL
``	NULL
.	NULL

However	NULL
,	NULL
this	NULL
study	NULL
provides	NULL
some	NULL
initial	NULL
clues	NULL
which	NULL
should	NULL
be	NULL
helpful	NULL
in	NULL
the	NULL
dissection	NULL
of	NULL
the	NULL
signal	NULL
transduction	NULL
pathways	NULL
utilized	NULL
by	NULL
the	NULL
G-CSF	NULL
receptor	NULL
.	NULL

REFERENCES	NULL
.	NULL

Demetri	NULL
,	NULL
G.	NULL
D.	NULL
,	NULL
and	NULL
Griffin	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Blood	NULL
78	NULL
,	NULL
2791-2808	NULL
.	NULL

Nagata	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Fukunaga	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Prog	NULL
.	NULL

Growth	NULL
Factor	NULL
Res	NULL
.	NULL

8	NULL
,	NULL
131-141	NULL
.	NULL

Nicola	NULL
,	NULL
N.	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

58	NULL
,	NULL
45-77	NULL
.	NULL

Fukunaga	NULL
,	NULL
R.	NULL
,	NULL
Seto	NULL
,	NULL
Y.	NULL
,	NULL
Mizushima	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Nagata	NULL
,	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
8702-8706	NULL
.	NULL

Fukunaga	NULL
,	NULL
R.	NULL
,	NULL
Ishizaka-Ikeda	NULL
,	NULL
E.	NULL
,	NULL
Pan	NULL
,	NULL
C.	NULL
X.	NULL
,	NULL
Seto	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Nagata	NULL
,	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
2855-2865	NULL
6	NULL
.	NULL

Yuo	NULL
,	NULL
A.	NULL
,	NULL
Kitagawa	NULL
,	NULL
S.	NULL
,	NULL
Azuma	NULL
,	NULL
E.	NULL
,	NULL
Natori	NULL
,	NULL
Y.	NULL
,	NULL
Togawa	NULL
,	NULL
A.	NULL
,	NULL
Saito	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Takaku	NULL
,	NULL
F.	NULL
(	NULL
1993	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1156	NULL
,	NULL
197-203	NULL
7	NULL
.	NULL

Wilhelmensen	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
Eggelton	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Temin	NULL
,	NULL
H.	NULL
M.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

52	NULL
,	NULL
172-182	NULL
8	NULL
.	NULL

Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
and	NULL
Gilden	NULL
,	NULL
R.	NULL
V.	NULL
(	NULL
1988	NULL
)	NULL
in	NULL
The	NULL
Oncogene	NULL
Handbook	NULL
(	NULL
Reddy	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Salka	NULL
,	NULL
A.	NULL
M.	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
eds	NULL
)	NULL
pp	NULL
.	NULL

495-512	NULL
,	NULL
Elsevier	NULL
,	NULL
New	NULL
York	NULL
9	NULL
.	NULL

Robinson	NULL
,	NULL
F.	NULL
R.	NULL
,	NULL
and	NULL
Tweihaus	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1974	NULL
)	NULL
Avian	NULL
Dis	NULL
.	NULL

18	NULL
,	NULL
278-288	NULL
10	NULL
.	NULL

Steward	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
288	NULL
,	NULL
692-694	NULL
11	NULL
.	NULL

Roth	NULL
,	NULL
S.	NULL
,	NULL
Stein	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Nusslein-Vollhard	NULL
,	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
1189-1202	NULL
12	NULL
.	NULL

Ip	NULL
,	NULL
Y.	NULL
T.	NULL
,	NULL
Kraut	NULL
,	NULL
R.	NULL
,	NULL
Levine	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Rushlow	NULL
,	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Celf	NULL
64	NULL
,	NULL
439-446	NULL
13	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Gifford	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Riviere	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1019-1029	NULL
14	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
961-969	NULL
15	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Logeat	NULL
,	NULL
F.	NULL
,	NULL
Vandekerckhove	NULL
,	NULL
J.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1007-1018	NULL
16	NULL
.	NULL

Kanakura	NULL
,	NULL
Y.	NULL
,	NULL
Druker	NULL
,	NULL
B.	NULL
,	NULL
Cannistra	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Furukawa	NULL
,	NULL
Y.	NULL
,	NULL
Torimoto	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Griffin	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Blood	NULL
76	NULL
,	NULL
706-715	NULL
17	NULL
.	NULL

Simek	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Rice	NULL
,	NULL
N.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

63	NULL
,	NULL
4730-4736	NULL
18	NULL
.	NULL

Neumann	NULL
,	NULL
M.	NULL
,	NULL
Tsapos	NULL
,	NULL
K.	NULL
,	NULL
Scheppler	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Ross	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Franza	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
Jr.	NULL
(	NULL
1992	NULL
)	NULL
Oncogene	NULL
7	NULL
,	NULL
2095-2104	NULL
19	NULL
.	NULL

Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
(	NULL
1970	NULL
)	NULL
Nature	NULL
227	NULL
,	NULL
680-685	NULL
20	NULL
.	NULL

Druker	NULL
,	NULL
B.	NULL
,	NULL
Okuda	NULL
,	NULL
K.	NULL
,	NULL
Matulonis	NULL
,	NULL
U.	NULL
,	NULL
Salgia	NULL
,	NULL
R.	NULL
,	NULL
Roberts	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Griffin	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
79	NULL
,	NULL
2215-2220	NULL
21	NULL
.	NULL

Franza	NULL
,	NULL
B.	NULL
R.	NULL
J.	NULL
,	NULL
Josephs	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Gilman	NULL
,	NULL
M.	NULL
Z.	NULL
,	NULL
Ryan	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Clarkson	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Nature	NULL
330	NULL
,	NULL
391-395	NULL
22	NULL
.	NULL

Hallek	NULL
,	NULL
M.	NULL
,	NULL
Druker	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Lepisto	NULL
,	NULL
E.	NULL
,	NULL
Wood	NULL
,	NULL
K.	NULL
,	NULL
Ernst	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Griffin	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Physiol	NULL
.	NULL

158	NULL
,	NULL
176-186	NULL
23	NULL
.	NULL

Okuda	NULL
,	NULL
K.	NULL
,	NULL
Sanghera	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Pelech	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Kanakura	NULL
,	NULL
Y.	NULL
,	NULL
Hallek	NULL
,	NULL
M.	NULL
,	NULL
Griffin	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Druker	NULL
,	NULL
B.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Blood	NULL
79	NULL
,	NULL
2880-2887	NULL
24	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1072	NULL
,	NULL
63-80	NULL
25	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
227-229	NULL
26	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
242	NULL
,	NULL
540-546	NULL
27	NULL
.	NULL

Davis	NULL
,	NULL
N.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Simmons	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Baltimore	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Bose	NULL
,	NULL
H.	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Science	NULL
258	NULL
,	NULL
1268-1271	NULL
28	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
344	NULL
,	NULL
678-682	NULL
29	NULL
.	NULL

Kerr	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
Inoue	NULL
,	NULL
J.	NULL
,	NULL
Davis	NULL
,	NULL
N.	NULL
,	NULL
Link	NULL
,	NULL
E.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Bose	NULL
,	NULL
H.	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
M.	NULL
,	NULL
V.	NULL
I	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
1464-1476	NULL
m	NULL
G0	NULL
Ro	NULL
i	NULL
of	NULL

